Projected Return Density against MarketAssuming 30 trading days horizon, Anhui Anke Biotechnology Group has beta of -0.56 . This suggests as returns on benchmark increase, returns on holding Anhui are expected to decrease at a much smaller rate. During bear market, however, Anhui Anke Biotechnology Group is likely to outperform the market. Additionally, Anhui Anke Biotechnology Group has negative alpha implying that risk taken by holding this securing is not justified. The company is significantly underperforming Shanghai Assuming 30 trading days horizon, the coefficient of variation of Anhui is -1858.51. The daily returns are destributed with a variance of 7.55 and standard deviation of 2.75. The mean deviation of Anhui Anke Biotechnology Group is currently at 2.12. For similar time horizon, the selected benchmark (Shanghai) has volatility of 0.81
Actual Return VolatilityAnhui Anke Biotechnology Group accepts 2.75% volatility on return distribution over the 30 days horizon. Shanghai accepts 0.94% volatility on return distribution over the 30 days horizon.
Follow Anhui Volatility with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Anhui Anke Biotechnology Group has a volatility of 2.75 and is 2.93 times more volatile than Shanghai. 36% of all equities and portfolios are less risky than Anhui. Compared with the overall equity markets, volatility of historical daily returns of Anhui Anke Biotechnology Group is lower than 36 (%) of all global equities and portfolios over the last 30 days. Use Anhui Anke Biotechnology Group to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. As returns on market increase, returns on owning Anhui are expected to decrease at a much smaller rate. During bear market, Anhui is likely to outperform the market.
Anhui correlation with market
Anhui Current Risk Indicators
Suggested Divercification Pairs